Events / Women in COG

13 May 2022

Women in COG: in conversation with Prof Emma Thomson

On Wednesday 29th June, at 12:15 – 13:00 BST, we will be hosting our next ‘Women in COG’ event featuring Emma Thomson, OBE, Professor in Infectious Diseases at the MRC-University of Glasgow Centre for Virus Research and a COG-UK Principal Investigator for the University of Glasgow.

This event will feature a conversation with Emma followed by an informal Q&A.

REGISTER HERE

When? Wednesday 29th June 12:15 to 13:00 BST

Where? Virtual

Who can attend? Everyone

 

Professor Emma Thomson, OBE

Professor Emma Thomson, OBE, is a COG-UK Principal Investigator for the University of Glasgow and a Professor in Infectious Diseases at the MRC-University of Glasgow Centre for Virus Research. She was recently awarded Officer of the Most Excellent Order of the British Empire (OBE) for services to the NHS during the COVID-19 response. Currently Professor Thomson is heavily involved in sequencing SARS-CoV-2 as part of COG-UK. She is the local principal investigator for two vaccine trials running within Greater Glasgow and Clyde. In addition to her work with COVID-19, Professor Thomson’s main research focus is on emerging infections in Uganda, working closely with the Uganda Virus Research Institute and in the UK.

 

About Women in COG

The COG-UK consortium has over 500 members with a range of scientific and business expertise in genomics, bioinformatics, operations clinical science and public health. Women in COG is a supportive network to share experience and knowledge and to promote science careers in women and girls.

This was an event in our series of monthly lunchtime Women in COG events and everyone (regardless of gender) is welcome to attend. The events will feature a conversation with a guest or consortium member followed by an informal Q&A.

Check out our past and upcoming Women in COG events.


COVID-19 Genomics UK (COG-UK)

The COVID-19 Genomics UK (COG-UK) consortium works in partnership to harness the power of SARS-CoV-2 genomics in the fight against COVID-19.

Led by Professor Sharon Peacock of the University of Cambridge, COG-UK is made up of an innovative collaboration of NHS organisations, the four public health agencies of the UK, the Wellcome Sanger Institute and sixteen academic partners. A full list of collaborators can be found here.

The COVID-19 pandemic, caused by SARS-CoV-2, represents a major threat to health. The COG-UK consortium was formed in March 2020 to deliver SARS-CoV-2 genome sequencing and analysis to inform public health policy and to support the establishment of a national pathogen sequencing service, with sequence data now predominantly generated by the Wellcome Sanger Institute and the Public Health Agencies.

SARS-CoV-2 genome sequencing and analysis plays a key role in the COVID-19 public health response by enabling the identification, tracking and analysis of variants of concern, and by informing the design of vaccines and therapeutics. COG-UK works collaboratively to deliver world-class research on pathogen sequencing and analysis, maximise the value of genomic data by ensuring fair access and data linkage, and provide a training programme to enable equity in global sequencing.